益佰制药: 贵州益佰制药股份有限公司2025年第一次临时股东大会会议资料

Core Points - Guizhou Yibai Pharmaceutical Co., Ltd. is holding its first extraordinary general meeting of shareholders in 2025 on September 5, 2025, with both on-site and online voting options available [1][2] - The agenda includes the proposal to abolish the supervisory board, transferring its responsibilities to the audit committee of the board of directors, and corresponding amendments to the company's articles of association [2][3] - The company aims to enhance its governance structure and operational efficiency through these changes, aligning with relevant laws and regulations [4][5] Proposal Summaries - Proposal 1: The company proposes to cancel the supervisory board, with its functions being assumed by the audit committee of the board of directors. This change is intended to streamline governance and improve operational management [2][3] - Proposal 2: Amendments to the company's articles of association are proposed to reflect the governance changes and ensure compliance with the Company Law and other relevant regulations [4][5] - Proposal 3: The meeting will also address the voting results and resolutions from the shareholders regarding the proposed changes, ensuring transparency and accountability in the decision-making process [2][3]